Serum N-glycan profiling is a potential biomarker for castration-resistant prostate cancer
Main Authors: | S. Hatakeyama, T. Yoneyama, Y. Tobisawa, H. Yamamoto, A. Imai, Y. Hashimoto, C. Ohyama |
---|---|
格式: | Article |
語言: | English |
出版: |
Elsevier
2020-07-01
|
叢編: | European Urology Open Science |
在線閱讀: | http://www.sciencedirect.com/science/article/pii/S2666168320336442 |
相似書籍
-
N‐glycan signature of serum immunoglobulins as a diagnostic biomarker of urothelial carcinomas
由: Hirotake Kodama, et al.
出版: (2021-02-01) -
Serum N-Glycan Profiling Predicts Prognosis in Patients Undergoing Hemodialysis
由: Shingo Hatakeyama, et al.
出版: (2013-01-01) -
Utility of plasma cell‐free DNA in metastatic castration‐resistant prostate cancer
由: Itsuto Hamano, et al.
出版: (2020-07-01) -
Clinical implications of serum N‐glycan profiling as a diagnostic and prognostic biomarker in germ‐cell tumors
由: Takuma Narita, et al.
出版: (2017-04-01) -
Hyaluronic acid degrading enzyme: TMEM2 increase in patients with interstitial cystitis and bladder pain syndrome
由: H. Yamamoto, et al.
出版: (2020-07-01)